000 01321 a2200313 4500
005 20250517033202.0
264 0 _c20160215
008 201602s 0 0 eng d
022 _a1548-8756
024 7 _a10.14694/EdBook_AM.2015.35.e41
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChia, Stephen K
245 0 0 _aNeoadjuvant and Adjuvant Therapy for HER2 Positive Disease.
_h[electronic resource]
260 _bAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
_c2015
300 _ae41-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProto-Oncogene Mas
650 0 4 _aReceptor, ErbB-2
_xantagonists & inhibitors
650 0 4 _aTrastuzumab
_xtherapeutic use
773 0 _tAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
_gp. e41-8
856 4 0 _uhttps://doi.org/10.14694/EdBook_AM.2015.35.e41
_zAvailable from publisher's website
999 _c24919080
_d24919080